Duvyzat (givinostat) — United Healthcare

Initial criteria

• Diagnosis of Duchenne muscular dystrophy (DMD)
• age ≥ 6 years

Reauthorization criteria

• Documentation of positive clinical response to Duvyzat therapy

Approval duration

12 months